oxandrolone has been researched along with Aging in 9 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to find out whether moderate doses of growth hormone (GH) in combination with oxandrolone (Ox) and late initiation of puberty could improve adult height even in relatively old patients with Ullrich-Turner syndrome (UTS)." | 9.10 | Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. ( Keller, E; Landy, H; Stahnke, N, 2002) |
| "The objective of this study was to find out whether moderate doses of growth hormone (GH) in combination with oxandrolone (Ox) and late initiation of puberty could improve adult height even in relatively old patients with Ullrich-Turner syndrome (UTS)." | 5.10 | Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. ( Keller, E; Landy, H; Stahnke, N, 2002) |
| "The retired breeder rat, an animal known to undergo premature aging and to develop hypercholesterolemia, was studied to determine the effect of oxandrolone, a synthetic hypolipidemic steroid, on serum lipoprotein subfractions." | 3.66 | The effect of oxandrolone on low and high density lipoprotein profiles in retired breeder rats. ( Freeman, MW; Jones, AL; Spring-Mills, E, 1980) |
| " Oxandrolone is reported to be generally well tolerated and the most commonly documented adverse effects are transient elevations in transaminase levels and reductions in high density lipoprotein cholesterol level." | 2.42 | The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. ( Fiatarone Singh, M; Orr, R, 2004) |
| "We have studied the course over age of fasting insulin, sex hormone-binding globulin (SHBG), and insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) in untreated children with Turner's syndrome (TS) and measured the course of these parameters during therapy with GH alone and in combination with oxandrolone." | 1.29 | Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. ( Blümel, P; Frisch, H; Haeusler, G; Plöchl, E; Schmitt, K; Waldhör, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RAY, CG | 1 |
| KIRSCHVINK, JF | 1 |
| WAXMAN, SH | 1 |
| KELLEY, VC | 1 |
| Orr, R | 1 |
| Fiatarone Singh, M | 1 |
| Schroeder, ET | 1 |
| Zheng, L | 1 |
| Ong, MD | 1 |
| Martinez, C | 1 |
| Flores, C | 1 |
| Stewart, Y | 1 |
| Azen, C | 1 |
| Sattler, FR | 1 |
| Freeman, MW | 1 |
| Spring-Mills, E | 1 |
| Jones, AL | 1 |
| Haeusler, G | 1 |
| Schmitt, K | 1 |
| Blümel, P | 1 |
| Plöchl, E | 1 |
| Waldhör, T | 1 |
| Frisch, H | 1 |
| Wolfe, R | 1 |
| Ferrando, A | 1 |
| Sheffield-Moore, M | 1 |
| Urban, R | 1 |
| Stahnke, N | 2 |
| Keller, E | 2 |
| Landy, H | 1 |
| Stubbe, P | 1 |
| Riggs, BL | 1 |
| Jowsey, J | 1 |
| Kelly, PJ | 1 |
| Hoffman, DL | 1 |
| Arnaud, CD | 1 |
2 reviews available for oxandrolone and Aging
| Article | Year |
|---|---|
The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.
Topics: Aging; Anabolic Agents; Androgens; Humans; Oxandrolone; Randomized Controlled Trials as Topic; Wasti | 2004 |
Testosterone and muscle protein metabolism.
Topics: Aged; Aging; Amino Acids; Anabolic Agents; Androstenedione; Growth Hormone; Humans; Male; Middle Age | 2000 |
3 trials available for oxandrolone and Aging
| Article | Year |
|---|---|
Effects of androgen therapy on adipose tissue and metabolism in older men.
Topics: Adipose Tissue; Aged; Aging; Androgens; Body Composition; Body Mass Index; Energy Intake; Energy Met | 2004 |
Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
Topics: Adolescent; Age Determination by Skeleton; Aging; Anabolic Agents; Body Height; Child; Cholesterol; | 2002 |
Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome.
Topics: Aging; Body Height; Body Weight; Bone Development; Child; Female; Growth Disorders; Growth Hormone; | 1992 |
4 other studies available for oxandrolone and Aging
| Article | Year |
|---|---|
STUDIES OF ANABOLIC STEROIDS. II. THE EFFECT OF OXANDROLONE ON HEIGHT AND SKELETAL MATURATION IN MONGOLOID CHILDREN (A PRELIMINARY REPORT).
Topics: Adolescent; Aging; Anabolic Agents; Body Height; Body Weight; Child; Down Syndrome; Epiphyses; Growt | 1963 |
The effect of oxandrolone on low and high density lipoprotein profiles in retired breeder rats.
Topics: Aging; Animals; Anticholesteremic Agents; Electrophoresis, Polyacrylamide Gel; Hypercholesterolemia; | 1980 |
Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
Topics: Adolescent; Aging; Child; Child, Preschool; Cross-Sectional Studies; Female; Growth Hormone; Humans; | 1996 |
Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis.
Topics: Aged; Aging; Animals; Biopsy; Bone Resorption; Calcitonin; Estrogens, Conjugated (USP); Female; Fluo | 1973 |